We are live on ! Find out more
HWM

HighMark Wealth Management Portfolio holdings

AUM $246M
1-Year Est. Return 35.95%
This Fund
S&P 500
This Quarter Est. Return
+0.4%
1 Year Est. Return
+35.95%
3 Year Est. Return
+84.22%
5 Year Est. Return
+86.67%
10 Year Est. Return
–
AUM
$166M
AUM Growth
+$4.72M
Cap. Flow
+$4.91M
Cap. Flow %
2.96%
Top 10 Hldgs %
72.14%
Holding
622
New
62
Increased
177
Reduced
49
Closed
35

Top Buys

Rank Stock Value
1
ATRC icon
AtriCure
ATRC
+$1.4M
2
NEO icon
NeoGenomics
NEO
+$1.27M
3
CNTA
Centessa Pharmaceuticals
CNTA
+$882K
4
ATEC icon
Alphatec Holdings
ATEC
+$582K
5
TRV icon
Travelers Companies
TRV
+$549K

Top Sells

Rank Stock Value
1
MODN
MODEL N, INC.
MODN
+$1.03M
2
TELA icon
TELA Bio
TELA
+$980K
3
EFV icon
iShares MSCI EAFE Value ETF
EFV
+$535K
4
IWM icon
iShares Russell 2000 ETF
IWM
+$319K
5
IUSV icon
iShares Core S&P US Value ETF
IUSV
+$82.3K

Sector Composition

Rank Sector Weight
1 Healthcare 10.57%
2 Financials 4.94%
3 Technology 3.85%
4 Industrials 1.42%
5 Consumer Staples 1.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DHR icon
76
Danaher
DHR
$135B
$140K 0.08%
560
– –
DIS icon
77
Walt Disney
DIS
$165B
$138K 0.08%
1,395
+18
+1% +$1.94K
WST icon
78
West Pharmaceutical
WST
$23.1B
$138K 0.08%
420
– –
VFL
79
DELISTED
abrdn National Municipal Income Fund
VFL
$136K 0.08%
12,880
– –
FAST icon
80
Fastenal
FAST
$54B
$135K 0.08%
4,284
– –
SPGI icon
81
S&P Global
SPGI
$126B
$134K 0.08%
300
– –
IBM icon
82
IBM
IBM
$202B
$131K 0.08%
759
+27
+4% +$4.69K
V icon
83
Visa
V
$677B
$123K 0.07%
470
+7
+2% +$1.92K
MDT icon
84
Medtronic
MDT
$107B
$123K 0.07%
1,560
+14
+0.9% +$1.15K
BABA icon
85
Alibaba
BABA
$269B
$122K 0.07%
1,689
-28
-2% -$2.15K
WBS icon
86
Webster Financial
WBS
$12.3B
$120K 0.07%
2,757
+24
+0.9% +$1.07K
SOLV icon
87
Solventum
SOLV
$13.5B
$119K 0.07%
+2,253
New +$137K
CAT icon
88
Caterpillar
CAT
$409B
$117K 0.07%
352
– –
PFE icon
89
Pfizer
PFE
$140B
$113K 0.07%
4,045
+2,243
+124% +$61.8K
JTEK icon
90
JPMorgan US Tech Leaders ETF
JTEK
$4.04B
$113K 0.07%
1,631
– –
CVX icon
91
Chevron
CVX
$388B
$110K 0.07%
702
-13
-2% -$2.07K
CVS icon
92
CVS Health
CVS
$137B
$109K 0.07%
1,846
-186
-9% -$11.6K
TYL icon
93
Tyler Technologies
TYL
$12.2B
$108K 0.07%
215
– –
AMD icon
94
Advanced Micro Devices
AMD
$851B
$105K 0.06%
647
-58
-8% -$9.33K
WDAY icon
95
Workday
WDAY
$33.4B
$103K 0.06%
459
– –
PYCR
96
DELISTED
Paycor HCM, Inc. Common Stock
PYCR
$98.2K 0.06%
7,730
+3,865
+100% +$57.8K
CSGP icon
97
CoStar Group
CSGP
$11.3B
$97.6K 0.06%
1,317
– –
GLOB icon
98
Globant
GLOB
$1.35B
$97.5K 0.06%
547
-8
-1% -$1.41K
MA icon
99
Mastercard
MA
$477B
$96.8K 0.06%
219
– –
ACWI icon
100
iShares MSCI ACWI ETF
ACWI
$32.6B
$95.1K 0.06%
846
+7
+0.8% +$769
2 3
4
5 6

Similar funds

PPA
Pilgrim Partners Asia Singapore $246M AUM
IRP
Investment Research Partners Lemont, Pennsylvania $246M AUM
EPIM
Equinox Partners Investment Management Stamford, Connecticut $245M AUM 225.58% 1-Year Est. Return
MAMHA
MY.Alpha Management HK Advisors Hong Kong $246M AUM 73.75% 1-Year Est. Return
RPCONE
Retirement Planning Company of New England Warwick, Rhode Island $246M AUM 27.83% 1-Year Est. Return
CSC
Caldwell Sutter Capital Sausalito, California $246M AUM 23.62% 1-Year Est. Return
NTCM
Nut Tree Capital Management New York $245M AUM 34.1% 1-Year Est. Return
VPA
Vernal Point Advisors San Francisco, California $246M AUM 12.97% 1-Year Est. Return

HighMark Wealth Management's Q2 2024 Portfolio in Review

As of Q2 2024, HighMark Wealth Management held 622 positions worth $166M, up 2.9% from $161M the previous quarter. Its ten largest holdings account for 72% of the portfolio.

HighMark Wealth Management's Q2 2024 filing shows 62 new, 177 increased, 49 reduced and 35 closed positions. Its largest new stake was Centessa Pharmaceuticals: 93,000 shares worth $840K. The largest sale was MODEL N, INC., an estimated $1.03M.

By sector, the portfolio is most concentrated in Healthcare at 11% of assets, up from 9.1% a quarter earlier, followed by Financials and Technology.

  • HighMark Wealth Management's largest Q2 2024 buy was Centessa Pharmaceuticals: 93,000 shares worth $840K.
  • HighMark Wealth Management added most to AtriCure in Q2 2024, an estimated $1.4M increase.
  • HighMark Wealth Management's biggest Q2 2024 reduction was TELA Bio, cutting an estimated $980K.
  • HighMark Wealth Management fully exited MODEL N, INC. in Q2 2024, selling an estimated $1.03M.
  • HighMark Wealth Management's ten largest holdings make up 72% of its $166M portfolio in Q2 2024.
  • HighMark Wealth Management opened 62 new positions and closed 35 in Q2 2024.
  • HighMark Wealth Management's portfolio value rose 2.9% quarter-over-quarter to $166M.

Based on HighMark Wealth Management's 13F filing for Q2 2024, filed 29 Jul 2024.